Patent details

EP3598975 Title: NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF

  • Data
  • Documents

Basic Information

Publication number:
EP3598975
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP183060177
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF
French Title of Invention:
NOUVELLES COMBINAISONS D'UN ANTAGONISTE H3 ET UN INHIBITEUR DE LA RECAPTURE DE LA NORADRÉNALINE ET LEURS UTILISATIONS THÉRAPEUTIQUES
German Title of Invention:
NEUARTIGE KOMBINATIONEN EINES H3-ANTAGONISTEN UND NORADRENALIN-WIEDERAUFNAHMEHEMMERS UND DEREN THERAPEUTISCHEN VERWENDUNGEN
SPC Number:

Dates

Filing date:
27/07/2018
Grant date:
21/10/2020
EP Publication Date:
29/01/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/10/2020
EP B1 Publication Date:
21/10/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/07/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/10/2020
 
 

Name:
Bioprojet
Address:
30 rue des Francs Bourgeois, 75003 Paris, France (FR)

Agent

Name:
LAVOIX
From:
22/10/2020
Address:
PLACE D'ESTIENNE D'ORVES 2, 75441, PARIS CEDEX 09, France (FR)
To:

Inventor

1

Name:
LECOMTE, Jeanne Marie
Address:
France (FR)

2

Name:
LANDAIS, Laurent
Address:
France (FR)

3

Name:
SCHWARTZ, Jean Charles
Address:
France (FR)

4

Name:
PERRIN, David
Address:
France (FR)

5

Name:
LIGNEAU, Xavier
Address:
France (FR)

Classification

IPC classification:
A61K 31/135; A61K 31/381; A61K 31/445; A61K 31/4545; A61K 31/535; A61K 31/55; A61K 45/06; A61P 25/00;

Publication

European Patent Bulletin

Issue number:
202043
Publication date:
21/10/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/06/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
ACUMASS SARL